8 completed, 3 recruiting, 3 terminated, 1 not yet recruiting. 15 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 15 | Completed 7, Recruiting 3, Terminated 3, Not yet recruiting 1, Withdrawn 1 |
Follow Lesaffre International: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S-Acetyl Glutathione and Performance Recovery in Soccer 200 mg S-Acetyl Glutathione, 500 mg S-Acetyl Glutathione, Placebo Supplementation - Performance Recovery, Exercise-induced Inflammation | Not applicable | Not yet recruiting | University of Thessaly | 20 | 2026-09-01 | 2026-07-08 |
| A Clinical Trial Evaluating the Influence of the Ingredients MyCondro™ and Bovine Chondroitin Sulfate on the Behavior of Cells in the Osteoarticular Sphere MyCondro™, Bovine chondroitin sulfate - Joint Health | Not applicable | Recruiting | Lesaffre International | 10 | 2026-08-26 | 2026-10-14 |
| A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health MyCondro 300mg, MyCondro 600mg - Joint Health | Not applicable | Completed | Lesaffre International | 240 | 2026-03-04 | 2026-09-30 |
| Relationship Between Skin Microbiome, Epigenetic Age, and Facial Features in Aging Healthy Female Volunteer | Completed | Lesaffre International | 100 | 2025-10-13 | 2026-02-24 | |
| Animal and Microbial-based Dietary Protein Efficiency in Adults Yeast Protein Supplement, Whey Protein Isolate Supplement, Collagen Hydrolysate Supplement - Protein Metabolism | Not applicable | Recruiting | Daniel Moore | 13 | 2025-07-01 | 2025-08-29 |
| Vitamin K2 Supplementation in Adult Episodic Migraine Vitamin K2 or menaquinone-7, Placebo - Migraine Headache, Arterial Stiffness | Not applicable | Recruiting | Sola Aoun Bahous, M.D. Ph.D. | 160 | 2024-03-06 | 2025-11-18 |
| Bioavailability Study of Folate in Healthy Subjects 5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2 - Healthy | Not applicable | Terminated | Lesaffre International | 12 | 2023-01-12 | 2024-01-05 |
| BSCU1 and Immune Function B. subtilis CU1 - General Population | Not applicable | Completed | Lesaffre International | 89 | 2022-06-07 | 2024-01-08 |
| Effect of Oral Probiotic Yeast on the Composition of the Vaginal Microbiota in Healthy Women Saccharomyces cerevisiae, dose 500, Saccharomyces cerevisiae, dose 1000, Placebo - Vaginal Health | Not applicable | Completed | Lesaffre International | 60 | 2018-03-01 | 2019-05-21 |
| Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype Saccharomyces cerevisiae CNCM I-3856, Placebo - Constipation-predominant Irritable Bowel Syndrome | Not applicable | Completed | Lesaffre International | 456 | 2017-03-20 | 2019-05-21 |
| Effect of Saccharomyces Cerevisiae in LDL Cholesterol Saccharomyces cerevisiae, Lynside Wall Basic, Placebo - Dyslipidemias | Not applicable | Completed | Lesaffre International | 201 | 2016-12-01 | 2018-06-12 |
| Effect of Saccharomyces Cerevisiae on Vulvo-vaginal Candidiasis Saccharomyces cerevisiae, Placebo - Candidiasis, Vulvovaginal | Not applicable | Terminated | Lesaffre International | 80 | 2016-08-01 | 2018-06-13 |
| Effect of Saccharomyces Cerevisiae on Improving the Effectiveness of Conventional Treatment of Vulvo-vaginal Candidiasis Saccharomyces cerevisiae, Placebo - Vulvo-vaginal Candidiasis | Not applicable | Terminated | Lesaffre International | 22 | 2015-01-01 | 2016-12-05 |
| Clinical Trial to Determine the Bioavailability of Three Different Zinc Preparations zinc-enriched yeast, Zinc references - Zinc Deficiency | Not applicable | Completed | Lesaffre International | 25 | 2014-10-01 | 2018-06-12 |
| Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome Saccharomyces cerevisiae CNCM I-3856, Placebo - Irritable Bowel Syndrome | Not applicable | Completed | Lesaffre International | 364 | 2011-12-01 | 2015-05-14 |
| Saccharomyces Cerevisiae CNCM I-3856 Treatment in Irritable Bowel Syndrome With Diarrhea (IBS-D) and Post Infective Bowel Dysfunction Saccharomyces Cerevisiae CNCM I-3856, placebo - Irritable Bowel Syndrome, Post Infective Bowel Dysfunction | Not applicable | Withdrawn | University of Nottingham | 2011-01-01 | 2017-06-20 |
Irritable Bowel Syndrome (2) · Candidiasis, Vulvovaginal (1) · Dyslipidemias (1) · Migraine Disorders (1) · Noonan syndrome 3 (1) · Vitamin K Deficiency (1)
Vitamin K 2 (1) · Zinc Oxide (1) · gluconic acid (1) · menaquinone 7 (1)
France (9) · Canada (1) · Greece (1) · Lebanon (1) · Netherlands (1) · United Kingdom (1) · United States (1)
Dimitrios Draganidis, PhD (1) · Noah Craft, MD, PhD (1) · Robert Cherbut, MD (1) · Robin Spiller, MB B Chir Cantab, MSc Lond, MD (1) · Sola Aoun Bahous, MD, PhD (1) · Yohann Wittrant (1)